SCHEMBL25328347

SCHEMBL25328347

CCc1cc(OCC(C)C)c(CC)c(C)c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1G O43497 2/20 0.40
CACNA1H O95180 2/20 0.40
CACNA1I Q9P0X4 2/20 0.40
ALDH1A1 P00352 4/20 0.38
HIF1A Q16665 1/20 0.38
TP53 P04637 1/20 0.35
THRB P10828 2/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 2/20 0.34
GPR55 Q9Y2T6 1/20 0.34
FOS P01100 1/20 0.33
JUN P05412 1/20 0.33
MYC P01106 1/20 0.32
MAX P61244 1/20 0.32
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
RXRG P48443 1/20 0.32
PKM P14618 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25327617 0.89 CACNA1G (0.40) CACNA1GCACNA1HCACNA1IALDH1A1HIF1A
SCHEMBL25329412 0.87 ALDH1A1 (0.40) CACNA1GCACNA1HCACNA1IALDH1A1HIF1A
SCHEMBL25329015 0.86 ALDH1A1 (0.39) CACNA1GCACNA1HCACNA1IALDH1A1HIF1A
SCHEMBL25329229 0.83 KDM4E (0.38) ALDH1A1THRBMAPTTSHRSMN1; SMN2
SCHEMBL25330323 0.81 ALDH1A1 (0.36) ALDH1A1MAPTTSHRTAAR1ALOX15
SCHEMBL25329985 0.81 MAPT (0.41) ALDH1A1TP53GAAMAPTGPR55
SCHEMBL25328760 0.79 ESR1 (0.40) ALDH1A1TP53MAPT
SCHEMBL25329653 0.78 TAAR1 (0.42) PKMTAAR1
SCHEMBL25327997 0.78 ALDH1A1 (0.37) CACNA1GCACNA1HCACNA1IALDH1A1HIF1A
SCHEMBL30356490 0.78 ALDH1A1 (0.37) CACNA1GCACNA1HCACNA1IALDH1A1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12583813-B2 Polymerization inhibitors BASF SE (DE) 2026-03-24 US disclosed
US-20230242472-A1 POLYMERIZATION INHIBITORS BASF SE (DE) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242472-A1 POLYMERIZATION INHIBITORS RCE1, CABLES1, DPYD CACNA1G 4725/4885CACNA1H 4785/4885CACNA1I 4347/4885
US-12583813-B2 Polymerization inhibitors PTGS1, PTGER1, POT1 CACNA1G 3847/4885CACNA1H 4012/4885CACNA1I 3320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.